Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state

Current Pharmaceutical Design

Volumn 19, Issue 13, 2013, Pages 2375-2381

  Grassi, Guido ^a,b   Buzzi, Silvia ^a   Dell'Oro, Raffaella ^a   Mineo, Claudia ^a   Dimitriadis, Kyriakos ^c   Seravalle, Gino ^d   Lonati, Laura ^d   Cuspidi, Cesare ^d  

^a SAN GERARDO HOSPITAL   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c UNIVERSITY OF ATHENS   (Greece)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Arterovenular ratio; High normal blood pressure; Hypertension; Organ damage; Retinal microcirculation; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADRENERGIC SYSTEM; ARTERIAL WALL THICKNESS; ARTERY OCCLUSION; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CAPILLARY FLOW; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FOLLOW UP; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; LASER DOPPLER FLOWMETRY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MICROCIRCULATION; NONHUMAN; PREHYPERTENSION; PRIORITY JOURNAL; RETINA; RETINOGRAPHY; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VASOCONSTRICTION;

BLOOD PRESSURE; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PREHYPERTENSION; RETINAL VESSELS;

EID: 84877806880     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319130005     Document Type: Article

References (51)

1. Keith NH, Wagener HP, Barker MW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939; 197: 332-43.
2. Heagerty AM, Heerkens EH, Izzard AS. Small arteries structure and function in hypertension. J Cell Mol Med 2010; 14: 1037-43.
3. Virdis A, Ghiadoni L, Versari D, Giannarelli C, Salvetti A, Taddei S. Endothelial function assessment in complicated hypertension. Curr Pharm Des 2008; 14: 1761-70.
4. Wong TY, Mitchell P. The eye in hypertension. Lancet 2007; 369: 425-35.
5. Cuspidi C, Negri F, Giudici V, Sala C. Retinal changes and cardiac remodelling in systemic hypertension. Ther Adv Cardiovasc Dis 2009; 3: 205-214.
6. Pose-Reino A, Gomez-Ulla F, Hayik B, et al. Computerized measurement of retinal blood vessel calibre: description, validation and use to determine the influence of ageing and hypertension. J Hypertens 2005; 23: 843-50.
7. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
8. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular diseases. N Engl J Med 2001 Nov 1; 345: 1291-7.
9. Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 2007; 335: 432.
10. Arima H, Murakami Y, Hing Lam T, et al; on behalf of the Asia Pacific Cohort Studies Collaboration. Effects of Prehypertension and Hypertension Subtype on Cardiovascular Disease in the Asia-Pacific Region. Hypertension 2012 Apr 30. [Epub ahead of print]
11. Guidelines Committee 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
12. Mancia G, De Backer G, Dominiczak A, et al 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
13. Psaty BM, Arnold AM, Olson J, et al. Association between levels of blood pressure and measures of subclinical disease multiethnic study of atherosclerosis. Am J Hypertens 2006; 19: 1110-7.
14. Mancia G, Facchetti R, Bombelli M, et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 2005; 45: 1072-7.
15. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Metabolic precursors of hypertension. The San Antonio Heart Study. Arch Intern Med 1996; 156: 1994-2001.
16. Bo S, Gambino R, Gentile L, et al. High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study. J Hypertens 2009; 27: 102-8.
17. Grassi G. Sympathetic and baroreflex function in hypertension: implications for current and new drugs. Curr Pharm Des 2004; 10: 3579-89.
18. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23: 1052-1058.
19. Johnson KS, Milla MD, Karp KA, Grunwald JF. Quantitative analysis of retinal vessel diameter reduction after photocoagulation treatment for retinopathy of prematurity. Am J Ophathalmology 2007; 143: 1030-2.
20. Sharrett AR, Hubbard LD, Cooper LS, et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150: 263-70.
21. Schmieder RE. Hypertensive rethinopathy: a window to vascular remodeling in arterial hypertension. Hypertension 2008; 51: 43-4.
22. Michelson G, Wetzenbach J, Pal I, Harazny J. Functional imaging of the retinal microvasculature by scanning laser Doppler flowmetry. Br J Ophtalmol 1998; 82: 1294-1300.
23. Hughes AD, Martinez-Perez E, Pal I, Harazny J. Functional imaging of the retinal microvasculature by scanning laser Doppler fluometry. Br J Ophatalmol 1998; 82: 1294-300.
24. Wong TY, Klein R, Sharrett AR, et al. Atherosclerosis Risk in Communities Study. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med 2004; 140: 248-55.
25. Cuspidi C, Meani S, Valerio C, et al. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of target organ Damage in Hypertension (ETODH) Study. Blood Press 2005; 14: 25-31.
26. Masaidi M, Cuspidi C, Giudici V, et al. Is retinal arteriolar-venular ratio associated with cardiac and extracardiac organ damage in essential hypertension. J Hypertens 2009; 27: 1277-83.
27. Liew G, Wang JJ, Cheung N, et al. The retinal vasculature as a fractal: methodology, reliability and relationship to blood pressure. Ophthalmology 2008; 115: 1951-6.
28. Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder ER. Impaired endothelial function of the retinal vasculature in hypertension. Stroke 2004; 35: 1269-93.
29. Ritt M, Harazny JM, Ott C, et al. Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens 2008; 26: 1427-33.
30. Harazny JM, Raff U, Welzenbach J, et al. New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens 2011; 29: 777-82.
31. Ritt M, Harazny, Ott C, et al. Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered reactivity to infusion of the nitric oxide synthase inhibitor N-momomethyl-larginine. J Hypertens 2009; 27: 2201-8.
32. Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relations with hypertension, cardiovascular disease and mortality. Surv Ophthalmol 2001; 46: 59-80.
33. Wong TY, Hubbard LD, Klein R, et al. Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol 2002; 86: 1007-13.
34. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Impact of current and past blood pressure on retinal arteriolar diameter in an older population. J Hypertens 2004; 22: 1543-9.
35. Smith W, Wang JJ, Wong TY, et al. Retinal arteriolar narrowing is associated with 5-year incident severe hypertension. The Blue Mountains Eye Study. Hypertension 2004; 44: 442-7.
36. Cuspidi C, Meani S, Salerno M, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 2095-102.
37. Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD. Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ 2004; 329: 79-82.
38. Cuspidi C, Meani S, Valerio C, et al. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study. Blood Press 2005; 14: 25-31.
39. Kawasaki R, Wang JJ, Rochtchina E, et al. Cardiovascular risk factors and retinal micro-vascular signs in an adult japanese population: the Funagata Study. Ophthalmology 2006; 113: 1378-84.
40. Chew SKH, Xie J, Wang JJ. Retinal arteriolar diameter and the prevalence and incidence of hypertension: a systematic review and meta-analysis of their association. Curr Hyperten Rep 2012; 14: 144-51.
41. Ritt M, Harazny JM, Ott C, et al. Basal NO activity is an independent dterminant of arteriolar structure in the human retinal circulation. J Hypertens 2011; 29: 123-9.
42. Cuspidi C, Dell'Oro R, Grassi G. Retinal arteriolar narrowing as marker of renal dysfunction: potential value and limitation. J Hypertens 2009; 27: 2162-4.
43. Sabaayagam C, Tai ES, Shankar A, Lee J, Sun C, Wong TY. Retinal arteriolar narrwing increases the likewood of chronic kidney disease in hypertension, J Hypertens 2009; 27: 2209-17.
44. Agabiti-Rosei E, Rizzoni D. Regression of small ressitance artery structural alterations in hypertension by appropiate antihypertensive treatment. Curr Hypertens Rep 2010; 12: 80-5.
45. Mancia G, Luscher TF, Shepherd JT, Noll G, Grassi G. Cardiovascular regulation: Basic considerations. In: Willerson JT, Cohn JN, Wellens HJJ, Holmes DR Jr. Eds. Cardiovascular Medicine. London: Springer Verlag 2007: pp 1525-36.
46. O' Rourke MF. Vascular impedance in studies of arterial and cardiac function. Physiol Rev 1982; 62: 570-623.
47. Failla M, Grappiolo A, Emanuelli G, et al. Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects. J Hypertens 1999; 17: 1117-23.
48. Grassi G, Giannattasio C, Failla M, et al. Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 1995; 26: 348-54.
49. Mangoni AA, Mircoli L, Giannattasio C, et al. Heart rate. dependance of arterial distensibility in vivo. J Hypertens 1996; 15: 897-901.
50. Mangoni AA, Mircoli L, Giannattasio C, et al. Effect of sympathectomy on mechanical properties of common carotid and femoral arteries. Hypertension 1997; 30: 1085-8.
51. Grassi G, Schmieder RE. The renaissance of the retinal microvascular network assessment in hypertension: new challenges. J Hypertens 2011; 29: 1289-91.